BSE filing, NSE: SYNCOMF. Summary written from the filing by ALFA Finder's alert engine.
Syncom Formulation (India) Ltd: key numbers
- Share price
- ₹19.95
- Market cap
- ₹1,875 Cr
- Revenue (annual)
- ₹489.2 Cr
- Net profit (annual)
- ₹76.44 Cr
- P/E (TTM)
- 21.9×Sector 42.0×
- Promoter holding
- 50.57%+0.00% QoQ
- FII holding
- 2.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syncom Formulation (India) Ltd
All →Syncom Formulation (India) Board Meeting Date
Syncom Formulations (India) Limited has scheduled a board meeting for November 13, 2026. The board will consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026.
Syncom Formulation (India) Other Announcement
Syncom Formulations (India) Limited filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Syncom Formulation (India) Dividend
Syncom Formulations (India) Ltd shareholders approved a final dividend of Rs. 0.10 per equity share at the 38th AGM, totaling Rs. 9.40 Crore.
- Value
- ₹9.40 Cr
Syncom Formulation (India) Management Change
Syncom Formulations (India) Limited announced the appointments of Rahul Vijay Bankda as Managing Director and Rinki Ankit Bankda as Whole Time Director. Ruchi Jindal was reappointed.
Syncom Formulation (India) Annual General Meeting
Syncom Formulations (India) Limited held its 38th Annual General Meeting on September 30, 2026, via video conferencing to transact various ordinary and special business items.
Syncom Formulation (India) Other Announcement
Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.
- Value
- ₹4.75 Cr
Other board meeting outcome announcements
All →CMX Holdings Board Meeting Outcome
Riwind Green Energy (formerly CMX Holdings) board approved altering its MOA main objects into six consolidated objects and a postal ballot notice. The change refocuses the company on solar, EPC, battery storage and renewable data-centre businesses.
Sahajanand Medical Technologies Board Meeting Outcome
Sahajanand Medical Technologies' board appointed M/s Amit Jaste & Associates as Secretarial Auditor for FY 2026-27 to FY 2030-31. The appointment is subject to shareholder approval.
- Execution
- FY 2026-27 to FY 2030-31, five consecutive financial years, subject to shareholder approval
Gretex Corporate Services Board Meeting Outcome
Gretex Corporate Services re-appointed Arvind Harlalka, Alok Harlalka and Rajiv Kumar Agarwal as directors after a board meeting. Terms are 60 months, effective from April 2027 and May 2027.
- Execution
- 60 months
Rajasthan Cylinders & Containers Board Meeting Outcome
Rajasthan Cylinders' board approved unaudited results for the quarter and half year ended September 30, 2026. The filing contains no financial figures.
Panasonic Carbon India Co Board Meeting Outcome
Panasonic Carbon's board recommended Brahmayya & Co. as statutory auditors for five years, from the 45th AGM in 2027. Standalone unaudited Q2 results were also approved.
- Execution
- Five years, from the conclusion of the 45th AGM (2027) to the conclusion of the 50th AGM (2032)
Safari Industries (India) Board Meeting Outcome
Safari Industries (India) Limited has approved a revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. The amendment ensures compliance with SEBI Regulations.